Ampio Pharmaceuticals, Inc.
AMPE
$0.0021
$0.0015250.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 47.16% | 56.75% | 20.38% | 22.92% | 4.32% |
| Total Depreciation and Amortization | -87.88% | -72.52% | -37.07% | -6.97% | -4.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 97.42% | 89.98% | 113.10% | -81.26% | -316.42% |
| Change in Net Operating Assets | 100.50% | -192.06% | -236.42% | -150.29% | -215.27% |
| Cash from Operations | 59.47% | 48.64% | 13.88% | -24.18% | -49.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 100.00% | 57.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -206.25% | 100.00% | 100.00% | 100.00% | 98.63% |
| Cash from Financing | 100.00% | -100.00% | -100.00% | -100.00% | -100.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.68% | -6,069.01% | -780.78% | -241.83% | -228.36% |